Welcome to TempusClinic

TempusClinic is the major clinic providing "Advanced Early Detection Diagnostics™" of life threatening diseases and the reversal of three primary chronic diseases: Type–2 Diabetes, Osteoporosis and Cardiovascular Disease through its proprietary "Metabolic Hormonal Transformation Therapeutics™".

Objective

Medical technology has been applied historically to late stage diagnosis and treatment. Now emerging medical technologies allow early disease detection when it is both less expensive and more effective to treat.

TempusClinic is a new type of business focusing on diminishing incidence of premature death and long–term suffering by using the best early detection technology and innovations in therapeutic recovery. The conventional medical model has not had a place for early detection and correction. TempusClinic is now the leader in the clinical application of Advanced Early Detection Diagnostics (AEDD™) and has developed an expert–system diagnostic and therapeutic model. It combines early stage diagnostic precision with intensive lifestyle intervention to extend peoples’ lives, reduce illness and significantly improve the quality of life.

About TempusClinic

Founder, Dr. Mike Nichols, exploited emerging technologies to solve early detection needs. This created the opportunity for early, timely treatment (origin of the Tempus name) thus improving disease outcomes. Extra time saves lives. Over 6% undergoing AEDD™ had immediate life threatening diseases that would not have been detected by other means1. They were immediately referred to the world’s top specialists.

The application of the TempusClinic AEDD™ has driven the need for a better early intervention therapeutic model.

The majority of diseases detected are metabolic in nature (e.g., diabetes, hypertension and heart disease) and when found early have no standardized medical treatment. TempusClinic developed Metabolic Hormonal Transformation Treatment™ (MHTT™) protocols and a suite of delivery tools, which includes an expert–system software management tool. Application of MHTT™ has shown auditable results demonstrating significant improvement in Type II Diabetes, Coronary Artery Disease, and Osteoporosis.

AEDD™ & MHTT™ products have been developed through prototype and are now being integrated into a commercial product line for rapid scalability. This scalable business model, "TempusCorporate", is a solid value proposition allowing companies to take a proactive approach to manage down healthcare costs and to improve employee productivity.

1Examples: Ascending Aortic Aneurysms, Abdominal Aneurysm, severe Coronary Artery Disease missed on Executive Physical, Hemochromatosis, Aneurysmal Septal Defects, severe Exercise Induced Hypertension, etc.
1"Exercise Capacity and Mortality Among Men…" N Engl J Med 2002;346:793–801, Mar 14, 2002

TempusClinic Advanced Early Detection Diagnostics (AEDD™) is the most advanced comprehensive diagnostic evaluation and physical examination commercially available including an individualized prescription for nutrition and exercise.

TempusClinic Metabolic–Hormonal Transformation (MHT) Program - The MHT Program is a one–year comprehensive personalized program that requires the AEDD™ as a starting point, then implements a client’s prescription for nutrition and exercise. The program is designed around the premise that the body wants to heal! TempusClinic provides a supervised environment rich with testing, retesting, feedback loops for course correction, and all of the elements necessary to vastly increase the probability of success towards a healthier you.

TempusClinic – White Papers and Press